Christian Angermayer discusses longevity and biotech investments
Christian Angermayer founder of discusses longevity investment, optimism regarding SPAC deal, and the light at the end the tunnel for biotech market.
Christian Angermayer, an entrepreneur and angel investor, will be one of the speakers on the Rejuvenation Summit for Startups in Berlin.
Angermayer, who manages more than $3 billion through Apeiron Investment Group is a leading figure in the longevity industry through his biotech platform companies Cambrian, and Rejuveron. He bases his work on his belief that people want to live longer, healthier lives.
Our editor-in chief caught up with Angermayer ahead of Berlin’s conference. He shared his views in a video interview on topics ranging from the biotech and longevity markets to what is happening with his $200 Million SPAC with David Sinclair, Peter Attia, and others.
Visit Longevity. Technology — https://bit.ly/3PwtH8Y
Follow the Longevity. Follow Longevity.
Twitter — https://bit.ly/3AMIXuq.
Facebook — https://bit.ly/3z8H1v5
Instagram — https://bit.ly/3IDvVRX
Linkedin — https://bit.ly/3yIfDmf
Source:
